Quantcast

Buckeye Reporter

Tuesday, April 22, 2025

FDA conducted second highest number of inspections on Biologics companies in Ohio during March

Webp 51tcce8qtq0gv3h0ttdr040fsao9

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

In March, three Biologics companies received three FDA inspections in Ohio, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Ohio, equalling 27.3% of all inspections in March.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Ohio During March
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products3
Compliance: Devices1
Foodborne Biological Hazards5
Monitoring of Marketed Animal Drugs, Feed, and Devices2
Postmarket Assurance: Devices1

MORE NEWS